GSK to cap out-of-pocket inhaler costs in US - Nasdaq

Mar 20, 2024 · British pharmaceutical giant GSK said on Wednesday it will cap out-of-pocket costs at $35 per month for all its inhaled asthma and chronic lung disease medicines for eligible patients in the ...

CouponFollow Extension

$35
OFF

GSK To Cap Out-of-pocket Inhaler Costs In US - Nasdaq

2 weeks from now

nasdaq.com

$35
OFF

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US

2 weeks from now

Mar 21, 2024 · TEVA. GSK plc GSK announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by …

yahoo.com

$35
OFF

GSK Announces Cap Of $35 Per Month On U.S. Patient Out-of …

2 weeks from now

Mar 20, 2024 · Announcement builds on GSK’s decades-long commitment to making products accessible to those who need them; GSK today announced it will cap out-of-pocket costs for …

gsk.com

$35
OFF

GSK To Cap Out-of-pocket Inhaler Costs In US | Reuters

2 weeks from now

March 20 (Reuters) - British pharmaceutical giant GSK (GSK.L) said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per …

reuters.com

$35
OFF

GSK Joins AstraZeneca, Boehringer In Capping US Out-of-pocket …

2 weeks from now

Mar 21, 2024 · Each drugmaker is capping out-of-pocket costs at $35 per month for their respective inhaler products. GSK's new price cap will take effect no later than January 1, …

fiercepharma.com

$35
OFF

UPDATE 1-GSK To Cap Out-of-pocket Inhaler Costs In US - Yahoo …

2 weeks from now

Mar 20, 2024 · British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month for …

yahoo.com

$35
OFF

Drug Companies Step Forward With Voluntary Price Caps On Inhalers

2 weeks from now

June 2, 2024. Drug companies Boehringer Ingelheim, AstraZeneca and GSK are capping out-of-pocket costs for their asthma inhalers at $35 per month for eligible patients.. The price caps for …

allergyasthmanetwork.org

$35
OFF

Now That Two Inhaler Makers Are Capping Patient Costs, Will …

2 weeks from now

Mar 18, 2024 · AstraZeneca’s move on Monday to cap at $35 the out-of-pocket costs that patients pay for the company’s Symbicort inhaler speaks to the political and regulatory pressure …

wsj.com

$35
OFF

Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler …

2 weeks from now

Senator Bernie Sanders Applauds GSK's Move To Cap Inhaler Costs At $35 Per Month. O n Wednesday, GSK Plc (NYSE:GSK) announced it will cap out-of-pocket costs for eligible …

msn.com

$35
OFF

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US

2 weeks from now

Mar 21, 2024 · GSK plc (GSK Quick Quote GSK - Free Report) announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, …

zacks.com

$35
OFF

These Inhalers No Longer Cost More Than $35 Per Month

2 weeks from now

Mar 26, 2024 · Amidst untenable drug prices, there's finally some good news: Several pharmaceutical companies are capping the out-of-pocket price of select inhalers at $35. …

verywellhealth.com

$35
OFF

GSK To Cap Out-of-pocket Inhaler Costs In US - KFGO

2 weeks from now

Mar 20, 2024 · (Reuters) – British pharmaceutical giant GSK said on Wednesday it will cap out-of-pocket costs at $35 per month for all its inhaled asthma and chronic lung disease medicines …

kfgo.com

$35
OFF

GSK Follows Rivals, To Cap Out-of-Pocket Inhaler Cost In US - MSN

2 weeks from now

GSK plc GSK announced plans to cap out-of-pocket expenses for its inhaled respiratory portfolio in the United States at $35 per month, following a similar move by rivals AstraZeneca AZN and ...

msn.com

$35
OFF

AstraZeneca To Cap Out-Of-Pocket Inhaler Costs In US, Following …

2 weeks from now

Mar 18, 2024 · REUTERS/Rachel Wisniewski/File Photo. (Reuters) -Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per …

usnews.com

$35
OFF

GSK To Cap Out-of-pocket Inhaler Costs In US - Dunya News

2 weeks from now

Mar 21, 2024 · (Reuters) – British pharmaceutical giant GSK said on Wednesday it would cap out-of-pocket costs for all its inhaled asthma and chronic lung disease medicines at $35 per month …

dunyanews.tv